Clinical trials
Placebo clinical trials
Below are recruiting placebo clinical trials, each written for real people, not researchers. We’re tracking 5,158 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07473570RecruitingPhase 1
Safety study of GS3-007a in healthy adults
This trial is testing a new medicine called GS3-007a (a dry powder you take mixed with liquid) to see if it's safe in healthy people. If you join, you'll help doctors understand how the body handles the drug and what side effects might occur.
Shanghai, Shanghai MunicipalityAges 18–45 - NCT07479173Recruiting
How a study ingredient affects protein digestion in healthy adults
This trial tests whether a study ingredient called P24 changes how your body breaks down and uses protein from a meal. It may help researchers understand ways to support muscle health as we age.
Davis, CaliforniaAges 45–75 - NCT07474545RecruitingPhase 1
Safety study of KL0011034 injection in healthy volunteers
This trial tests a new injection called KL0011034 to see if it is safe and how the body processes it. Healthy volunteers aged 18–45 who meet specific health and lifestyle criteria can join.
Changsha, HunanAges 18–45 - NCT07473323RecruitingPhase 1
Testing a new drug for healthy adults and those with diabetic kidney disease
This trial tests a new medication called MTX-439. It includes healthy adults and people with diabetic kidney disease to see if the drug is safe and to learn how the body handles it.
Melbourne, VictoriaAges 18–65 - NCT07473713RecruitingPhase 1
Veverimer for bone loss in adults with osteopenia
This study tests whether a medication called veverimer can help reduce bone loss in adults with osteopenia (early bone thinning) by lowering the acid load from their diet. Participants must be 50 or older, eat a typical Western diet, and have low bone density but not full osteoporosis.
Boston, MassachusettsAges 50 years+ - NCT07474831Recruiting
Probiotic treatment to prevent repeat vaginal infections
This trial tests whether taking a probiotic (a beneficial bacteria) can reduce the number of times you get bacterial vaginosis, a common vaginal infection. It may help you have fewer infections in the future.
Forlì, Emilia-RomagnaAges 18–45 - NCT07479602RecruitingPhase 4
Medicine via nose for less pain after tonsil surgery in kids
This trial tests whether giving two medicines (dexmedetomidine and esketamine) through the nose can help children ages 3-7 have less pain after their tonsil or adenoid surgery. The goal is to find a better way to manage pain without using strong drugs.
Beijing, Beijing MunicipalityAges 3–7 - NCT07472426Recruiting
Creatine for brain and kidney health after exercise in heat
This study tests if taking creatine supplements can protect your brain and kidneys during intense exercise in hot conditions. You'll exercise and have your thinking and kidney function checked afterward.
Cedar Falls, IowaAges 18–45 - NCT07477431RecruitingPhase 2
Testing levetiracetam for those at risk of Alzheimer's
This trial tests if a medication called levetiracetam (a drug usually used for seizures) can help protect memory in people who are at higher risk for Alzheimer's but do not yet have memory problems. It involves brain scans and cognitive tests to see if the drug can reduce overactive brain activity linked to memory loss.
Toronto, OntarioAges 55–85 - NCT07479290RecruitingPhase 1
Vitamin D gel to speed up tooth movement after extraction
This trial tests whether applying vitamin D near the extraction site can speed up how quickly your canine teeth move into the gap after premolars are removed. It might help shorten your orthodontic treatment.
Islamabad, FederalAges 13 years+ - NCT07480161RecruitingPhase 2/Phase 3
Stem cell and exosome therapy for diabetic erectile dysfunction
This trial tests whether a treatment made from stem cells and their cell messengers (exosomes) can help men with diabetes and erectile dysfunction who have not been helped by standard treatments. The goal is to see if this therapy can improve erections and offer a less invasive option than a penile implant.
Ankara, AnkaraAges 25–75 - NCT07479966Enrolling by invitation
Brain connectivity and placebo response study
This trial examines how brain connectivity relates to differences in how people respond to placebos. It may help understand individual responses to treatments.
Hamburg, Free and Hanseatic City of HamburgAges 18–35 - NCT06780410RecruitingPhase 3
Study of bempedoic acid for lowering cholesterol
This trial tests a drug called bempedoic acid to see if it can safely help lower cholesterol in adults. It may be an option if you have high cholesterol and need a different treatment.
BeijingAges 18 years+ - NCT06208527RecruitingPhase 2
Nicotinamide Riboside for Frailty in Older Adults
This trial tests whether a daily supplement called nicotinamide riboside can help older adults who feel weak or frail to get stronger and more energetic. It lasts for several months and involves simple tests like a walking test and memory checks.
Bergen, VestlandAges 75 years+ - NCT06716151RecruitingPhase 1
HB0034 study for healthy Chinese adults
This trial tests a new medicine called HB0034 in healthy volunteers. It helps researchers understand how the drug works in the body before testing it in people with a medical condition.
Jinan, ShandongAges 18–45 - NCT06782594RecruitingPhase 2
Mosapride injection for bowel recovery after surgery
This trial tests an injectable medicine, mosapride citrate, to help the gut start working again after laparoscopic intestinal surgery. It may reduce bloating, pain, and time to first bowel movement.
Feixian, ShandongAges 18–75 - NCT05421325RecruitingPhase 2
Vaccine-like immune treatment to prevent lung infections in seniors
This Phase 2 study tests a site-specific immune “booster” in people age 65 and older to help improve natural immunity and reduce respiratory (lung/airway) infections. You may be eligible if you can consent, are in an eligible living situation, and are not currently using certain immune-suppressing medicines.
Burnaby, British ColumbiaAges 65 years+ - NCT06702124RecruitingPhase 3
Rotigotine patch with rivastigmine for mild to moderate Alzheimer's
This trial tests if adding a rotigotine patch to your usual rivastigmine treatment can help with symptoms of Alzheimer's. It is for people with mild to moderate Alzheimer's who have been stable on rivastigmine for at least 3 months.
Rome, ItalyAges 50–85 - NCT06499324RecruitingPhase 3
Surgery plus Botox for large incisional hernia
This trial tests whether adding Botox injections to surgery helps repair large incisional hernias. It may lower the chance of the hernia coming back.
Colombes, FranceAges 18–79 - NCT06351150RecruitingPhase 3
Testing angiotensin II for refractory distributive shock
This study tests an injection of angiotensin II (a substance that helps tighten blood vessels) versus a placebo for patients with distributive shock that is not responding to standard treatments. It may help raise blood pressure and improve outcomes.
Hefei, AnhuiAges 18 years+ - NCT07463183RecruitingPhase 2
Study of MK-8690 for moderate to severe ulcerative colitis
This trial tests an investigational drug called MK-8690 for people with moderate to severe ulcerative colitis (UC) who haven't responded well to other treatments or can't tolerate them. The study aims to see if the drug can help control UC symptoms safely.
Anaheim, CaliforniaAges 18–75 - NCT07465653RecruitingPhase 1
Study of HJB647 for heart failure with reduced pumping ability
This trial tests a new medicine, HJB647, in people with heart failure who have a weak heart pump. It aims to see if the drug is safe and well-tolerated. You may qualify if your heart's pumping ability is reduced and you are on a specific standard therapy.
Bradenton, FloridaAges 18–100 - NCT07469085RecruitingPhase 1
Safety study of SV003 in healthy volunteers
This trial tests a new medication called SV003 in healthy people to see if it's safe and how the body processes it. You may be able to join if you are in good health and meet certain weight and lifestyle requirements.
ShanghaiAges 18–45 - NCT07469800RecruitingPhase 3
IBI362 for high blood pressure in overweight adults
This study tests an injectable medicine (IBI362) to see if it helps lower blood pressure in people who are overweight or have obesity. You may be eligible if you have high blood pressure but are not currently taking medication for it, and you do not have diabetes or major heart problems.
Shanghai, Shanghai MunicipalityAges 18 years+
Hear when a new Placebo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo?
- Yes. Clin2 currently lists 5,158 recruiting placebo studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.